Ann: Opthea Announces Decision to Discontinue Wet AMD Trials, page-61

  1. 835 Posts.
    lightbulb Created with Sketch. 224
    Doctor, do you think the two abnormally strong control groups are not worth the management to investigate the implementation of the clinical trial? Or is opt-302 really dead and not worth doing another clinical trial (if it is due to the COVID-19 pandemic)? Why does the management seem to assume that the control group is so excellent?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
60.0¢
Change
0.000(0.00%)
Mkt cap ! $738.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.